{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:10:43Z","timestamp":1772766643021,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10549-013-2452-y","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T04:13:33Z","timestamp":1362197613000},"page":"571-579","source":"Crossref","is-referenced-by-count":12,"title":["Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women"],"prefix":"10.1007","volume":"138","author":[{"given":"Adana A.","family":"Llanos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore M.","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona G.","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalin","family":"Marian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kepher H.","family":"Makambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar V. S.","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"Spear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael J.","family":"Convit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Platek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile L.","family":"Adams-Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo L.","family":"Freudenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"2452_CR1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1005998832636","volume":"47","author":"DL Kleinberg","year":"1998","unstructured":"Kleinberg DL (1998) Role of IGF-I in normal mammary development. Breast Cancer Res Treat 47:201\u2013208","journal-title":"Breast Cancer Res Treat"},{"key":"2452_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1005950916707","volume":"47","author":"MN Pollak","year":"1998","unstructured":"Pollak MN (1998) Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat 47:209\u2013217","journal-title":"Breast Cancer Res Treat"},{"key":"2452_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000066230","volume":"63","author":"SJ Moschos","year":"2002","unstructured":"Moschos SJ, Mantzoros CS (2002) The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63:317\u2013332","journal-title":"Oncology"},{"key":"2452_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1677\/erc.0.0080197","volume":"8","author":"D Sachdev","year":"2001","unstructured":"Sachdev D, Yee D (2001) The IGF system and breast cancer. Endocr Relat Cancer 8:197\u2013209","journal-title":"Endocr Relat Cancer"},{"key":"2452_CR5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1152\/physrev.1996.76.4.1005","volume":"76","author":"CE Stewart","year":"1996","unstructured":"Stewart CE, Rotwein P (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005\u20131026","journal-title":"Physiol Rev"},{"key":"2452_CR6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1006\/bbrc.1997.7089","volume":"237","author":"T Nickerson","year":"1997","unstructured":"Nickerson T, Huynh H, Pollak M (1997) Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochem Biophys Res Commun 237:690\u2013693","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2452_CR7","first-page":"3","volume":"16","author":"JI Jones","year":"1995","unstructured":"Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16(1):3\u201334","journal-title":"Endocr Rev"},{"key":"2452_CR8","first-page":"726","volume":"11\u201312","author":"O Ali","year":"2003","unstructured":"Ali O, Cohen P, Lee KW (2003) Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule. Horm Metab Res 11\u201312:726\u2013733","journal-title":"Horm Metab Res"},{"key":"2452_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1359-6101(96)00053-6","volume":"8","author":"DR Clemmons","year":"1997","unstructured":"Clemmons DR (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8:45\u201362","journal-title":"Cytokine Growth Factor Rev"},{"key":"2452_CR10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","volume":"11","author":"TJ Key","year":"2010","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet oncol 11:530\u2013542","journal-title":"Lancet oncol"},{"key":"2452_CR11","first-page":"1566","volume":"11","author":"RA Krajcik","year":"2002","unstructured":"Krajcik RA, Borofsky ND, Massardo S, Orentreich N (2002) Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11:1566\u20131573","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-009-0609-5","volume":"121","author":"DE Rollison","year":"2010","unstructured":"Rollison DE et al (2010) Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat 121:661\u2013669","journal-title":"Breast Cancer Res Treat"},{"key":"2452_CR13","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8","volume":"88","author":"P Toniolo","year":"2000","unstructured":"Toniolo P et al (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88:828\u2013832","journal-title":"Int J Cancer"},{"key":"2452_CR14","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393\u20131396","journal-title":"Lancet"},{"key":"2452_CR15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1158\/1055-9965.EPI-06-0960","volume":"16","author":"L Baglietto","year":"2007","unstructured":"Baglietto L et al (2007) Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 16:763\u2013768","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1677\/erc.1.01150","volume":"13","author":"S Rinaldi","year":"2006","unstructured":"Rinaldi S et al (2006) IGF-I, IGFBP-3 and breast cancer risk in women: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13:593\u2013605","journal-title":"Endocr Relat Cancer"},{"key":"2452_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1022518321634","volume":"14","author":"NE Allen","year":"2003","unstructured":"Allen NE et al (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14:65\u201374","journal-title":"Cancer Causes Control"},{"key":"2452_CR18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1158\/1055-9965.1444.13.9","volume":"13","author":"K DeLellis","year":"2004","unstructured":"DeLellis K et al (2004) Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 13:1444\u20131451","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1677\/ERC-09-0023","volume":"17","author":"JH Fowke","year":"2010","unstructured":"Fowke JH et al (2010) Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Endocr Relat Cancer 17:51\u201360","journal-title":"Endocr Relat Cancer"},{"key":"2452_CR20","first-page":"377","volume":"10","author":"H Jernstrom","year":"2001","unstructured":"Jernstrom H et al (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10:377\u2013384","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-004-0746-9","volume":"88","author":"H Johansson","year":"2004","unstructured":"Johansson H et al (2004) Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Breast Cancer Res Treat 88:63\u201373","journal-title":"Breast Cancer Res Treat"},{"key":"2452_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00008469-200110000-00008","volume":"10","author":"A Lukanova","year":"2001","unstructured":"Lukanova A et al (2001) A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 10:443\u2013452","journal-title":"Eur J Cancer Prev"},{"key":"2452_CR23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10552-005-2702-3","volume":"16","author":"LM Morimoto","year":"2005","unstructured":"Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD (2005) Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States). Cancer Causes Control 16:917\u2013927","journal-title":"Cancer Causes Control"},{"key":"2452_CR24","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/bcr2093","volume":"10","author":"C Diorio","year":"2008","unstructured":"Diorio C, Brisson J, Berube S, Pollak M (2008) Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study. Breast Cancer Res 10:R42","journal-title":"Breast Cancer Res"},{"key":"2452_CR25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/01635580701328073","volume":"58","author":"HendersonK DeLellis","year":"2007","unstructured":"DeLellis HendersonK et al (2007) Lifestyle and dietary correlates of plasma insulin-like growth factor binding protein-1 (IGFBP-1), leptin, and C-peptide: the Multiethnic Cohort. Nutr Cancer 58:136\u2013145","journal-title":"Nutr Cancer"},{"key":"2452_CR26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.annepidem.2009.08.005","volume":"19","author":"JM Faupel-Badger","year":"2009","unstructured":"Faupel-Badger JM, Berrigan D, Ballard-Barbash R, Potischman N (2009) Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race\/ethnicity and gender. Ann Epidemiol 19:841\u2013849","journal-title":"Ann Epidemiol"},{"key":"2452_CR27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1158\/1055-9965.EPI-12-0016","volume":"21","author":"AA Llanos","year":"2012","unstructured":"Llanos AA et al (2012) Adipokines in plasma and breast tissues: associations with breast cancer risk factors. Cancer Epidemiol Biomarkers Prev 21:1745\u20131755","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1582-4934.2009.00924.x","volume":"14","author":"RG Dumitrescu","year":"2010","unstructured":"Dumitrescu RG et al (2010) Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women. J Cell Mol Med 14:1468\u20131475","journal-title":"J Cell Mol Med"},{"key":"2452_CR29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/sj.bjc.6602471","volume":"92","author":"NE Allen","year":"2005","unstructured":"Allen NE et al (2005) A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 92:1283\u20131287","journal-title":"Br J Cancer"},{"key":"2452_CR30","first-page":"199","volume":"24","author":"T Agurs-Collins","year":"2000","unstructured":"Agurs-Collins T, Adams-Campbell LL, Kim KS, Cullen KJ (2000) Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women. Cancer Detect Prev 24:199\u2013206","journal-title":"Cancer Detect Prev"},{"key":"2452_CR31","first-page":"193","volume":"29","author":"Z Kahan","year":"2006","unstructured":"Kahan Z et al (2006) Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. Int J Oncol 29:193\u2013200","journal-title":"Int J Oncol"},{"key":"2452_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","volume":"101","author":"MJ Gunter","year":"2009","unstructured":"Gunter MJ et al (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101:48\u201360","journal-title":"J Natl Cancer Inst"},{"key":"2452_CR33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1015270324325","volume":"13","author":"R Kaaks","year":"2002","unstructured":"Kaaks R et al (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13:307\u2013316","journal-title":"Cancer Causes Control"},{"key":"2452_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12672-010-0013-y","volume":"1","author":"CM Schairer","year":"2010","unstructured":"Schairer CM, Isaacs C, Sue LY, Pollak MN, Berg CD, Ziegler RG (2010) Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) Cohort. Horm Cancer 1:100\u2013111","journal-title":"Horm Cancer"},{"key":"2452_CR35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/erc.1.01149","volume":"13","author":"ES Schernhammer","year":"2006","unstructured":"Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE (2006) Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer 13:583\u2013592","journal-title":"Endocr Relat Cancer"},{"key":"2452_CR36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-04-0561","volume":"14","author":"ES Schernhammer","year":"2005","unstructured":"Schernhammer ES, Holly JM, Pollak MN, Hankinson SE (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:699\u2013704","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10549-011-1734-5","volume":"131","author":"RT Falk","year":"2012","unstructured":"Falk RT et al (2012) Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Breast Cancer Res Treat 131:287\u2013294","journal-title":"Breast Cancer Res Treat"},{"key":"2452_CR38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/clinchem\/45.8.1384","volume":"45","author":"CJ Rosen","year":"1999","unstructured":"Rosen CJ (1999) Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 45:1384\u20131390","journal-title":"Clin Chem"},{"key":"2452_CR39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jcb.240520211","volume":"52","author":"JA Figueroa","year":"1993","unstructured":"Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D (1993) Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 52:196\u2013205","journal-title":"J Cell Biochem"},{"key":"2452_CR40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000292493","volume":"38","author":"H Jernstrom","year":"1994","unstructured":"Jernstrom H, Olsson H (1994) Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives. Gynecol Obstet Invest 38:261\u2013265","journal-title":"Gynecol Obstet Invest"},{"key":"2452_CR41","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1158\/1055-9965.EPI-10-0428","volume":"19","author":"L Rosenberg","year":"2010","unstructured":"Rosenberg L, Boggs DA, Wise LA, Adams-Campbell LL, Palmer JR (2010) Oral contraceptive use and estrogen\/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev 19:2073\u20132079","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kwn360","volume":"169","author":"L Rosenberg","year":"2009","unstructured":"Rosenberg L, Zhang Y, Coogan PF, Strom BL, Palmer JR (2009) A case-control study of oral contraceptive use and incident breast cancer. Am J Epidemiol 169:473\u2013479","journal-title":"Am J Epidemiol"},{"key":"2452_CR43","doi-asserted-by":"crossref","first-page":"e1001182","DOI":"10.1371\/journal.pmed.1001182","volume":"9","author":"M Urban","year":"2012","unstructured":"Urban M et al (2012) Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South african women: case-control study. PLoS Med 9:e1001182","journal-title":"PLoS Med"},{"key":"2452_CR44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ghir.2008.08.005","volume":"19","author":"D Berrigan","year":"2009","unstructured":"Berrigan D et al (2009) Race\/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res 19:146\u2013155","journal-title":"Growth Horm IGF Res"},{"key":"2452_CR45","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1055-9965.EPI-04-0944","volume":"14","author":"SP Pinheiro","year":"2005","unstructured":"Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE (2005) Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 14:2147\u20132153","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2452_CR46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0027-9684(15)31344-4","volume":"100","author":"GJ Morris","year":"2008","unstructured":"Morris GJ, Mitchell EP (2008) Higher incidence of aggressive breast cancers in African-American women: a review. J Natl Med Assoc 100:698\u2013702","journal-title":"J Natl Med Assoc"},{"key":"2452_CR47","first-page":"16","volume":"25","author":"DP Rose","year":"2001","unstructured":"Rose DP, Royak-Schaler R (2001) Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev 25:16\u201331","journal-title":"Cancer Detect Prev"},{"key":"2452_CR48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-010-0827-x","volume":"121","author":"BK Dunn","year":"2010","unstructured":"Dunn BK, Agurs-Collins T, Browne D, Lubet R, Johnson KA (2010) Health disparities in breast cancer: biology meets socioeconomic status. Breast Cancer Res Treat 121:281\u2013292","journal-title":"Breast Cancer Res Treat"},{"key":"2452_CR49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1008801131831","volume":"10","author":"KM Egan","year":"1999","unstructured":"Egan KM et al (1999) The relation of breast size to breast cancer risk in postmenopausal women (United States). Cancer Causes Control 10:115\u2013118","journal-title":"Cancer Causes Control"},{"key":"2452_CR50","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/ijc.21588","volume":"118","author":"AS Kusano","year":"2006","unstructured":"Kusano AS et al (2006) A prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 118:2031\u20132034","journal-title":"Int J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2452-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2452-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2452-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T19:16:31Z","timestamp":1715022991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2452-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2452"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2452-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]}}}